Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE Next Article
Anifrolumab achieves rapid and durable BICLA-response »
« Wide variation in prescription and dosing patterns for hydroxychloroquine in SLE Next Article
Anifrolumab achieves rapid and durable BICLA-response »
Table of Contents: EULAR 2020
Featured articles
COVID-19 and inflammatory rheumatic disease: some key issues
Secukinumab monotherapy as efficient as adalimumab
AxSpA real-life remission rates higher on biologics
Olokizumab significantly improves RA features and patient-reported outcomes
Rheumatoid Arthritis
New nanoparticle promising future agent in RA
Olokizumab significantly improves RA features and patient-reported outcomes
Low DAS at 4 months predicts sustained DMARD-free remission
Ankylosing Spondylitis
Reduced maintenance dose of certolizumab pegol can be used in axSpA
Worse response axSpA patients to second TNFi versus first TNFi
AxSpA real-life remission rates higher on biologics
Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis
TNF-α inhibitors improve bone mineral density in AS patients
Psoriatic Arthritis
Ixekizumab shows sustained improvements in pain and fatigue at 3 years
Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio
Upadacitinib provides fast onset of improvement in psoriatic arthritis
Secukinumab monotherapy as efficient as adalimumab
Osteoporosis and Osteoarthritis
Higher mortality risk with tramadol versus NSAIDs for osteoarthritis patients
Hydroxychloroquine not effective in patients with hand osteoarthritis
Positive effect denosumab on fall risk
Systemic Sclerosis and Systemic Lupus Erythematosus
Anifrolumab achieves rapid and durable BICLA-response
Subclinical myocardial involvement progresses in SSc patients
Composite endpoint CRESS for primary Sjögren’s syndrome
COVID-19
COVID-19 and inflammatory rheumatic disease: some key issues
Related Articles
September 4, 2019
Short methotrexate stop is safe in patients with RA
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy